What You Should Know: Clario announced an expansion to its collaboration with AliveCor to enable trial participants to collect medical-grade six-lead ECG readings in the comfort of their own homes through KardiaRx, a clinical-trial-focused…
Continue Reading
Funding Intended to Fuel Continued Innovation of RapidAI’s Advanced Clinical Decision and Workflow Support Technology Further Establish a Leadership Position in Clinical AI Solutions
RapidAI, a global leader in developing Artificial Intelligence (AI) and technology…
Machine learning-based algorithms can now be used to help detect atrial fibrillation, asymptomatic left ventricular systolic dysfunction, and cardiac amyloidosis. Even more digital diagnostic tools are on the drawing board.
By John Halamka, M.D., President,…
Continue Reading
Researchers at Northwestern University have developed a cardiac monitoring device that is intended for use in patients who have suffered a cardiac event. The soft and flexible patch can be affixed to the outside…
Continue Reading
What You Should Know:
Geisinger, an integrated health care delivery and coverage organization serving members in central and northeastern Pennsylvania forms a strategic collaboration with Bodyport, a virtual care company focused on heart failure to…
Continue Reading
What You Should Know:
UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced that it has been granted FDA clearance for its AI-powered ultrasound guidance technology. The UltraSight real-time AI…
Continue Reading
Background: Cardiac telerehabilitation offers a flexible and accessible model for patients with coronary artery disease (CAD), effectively transforming the traditional cardiac rehabilitation (CR) approach. Objective: This systematic review and meta-analysis aimed to evaluate the…
Continue Reading
What You Should Know:
– RapidAI, a San Mateo, CA-based digital health company developing artificial intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced $75 million in Series…
Continue Reading
Background: During flight, G force compels blood to stay in leg muscles and reduces blood flow to the heart. Cardiovascular responses activated by the autonomic nerve system and strengthened by anti-G straining maneuvers can…
Continue Reading
By Shania Kennedy
July 17, 2023 – A deep learning (DL) model has been developed and validated to estimate cardiac function and valvular disease using chest radiographs, according to a study published this month in The…
Continue Reading
